BioLineRx Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Go back to BioLineRx Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.26 +0.02 (0.62%)
Previous Close $3.24    52 Week High $1.63 
Open $3.23    52 Week Low $0.71 
Day High $3.45    P/E N/A 
Day Low $3.23    EPS $0.00 
Volume 74,144       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.26 +0.02 (0.62%)
Previous Close $3.24    52 Week High $1.63 
Open $3.23    52 Week Low $0.71 
Day High $3.45    P/E N/A 
Day Low $3.23    EPS $0.00 
Volume 74,144       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.26 +0.02 (0.62%)
Previous Close $3.24    52 Week High $1.63 
Open $3.23    52 Week Low $0.71 
Day High $3.45    P/E N/A 
Day Low $3.23    EPS $0.00 
Volume 74,144       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.26 +0.02 (0.62%)
Previous Close $3.24    52 Week High $1.63 
Open $3.23    52 Week Low $0.71 
Day High $3.45    P/E N/A 
Day Low $3.23    EPS $0.00 
Volume 74,144